Artikel dengan mandat akses publik - Josse ClairePelajari lebih lanjut
Tidak tersedia di mana pun: 1
Neoadjuvant chemotherapy in breast cancer patients induces miR‐34a and miR‐122 expression
P Freres, C Josse, N Bovy, M Boukerroucha, I Struman, V Bours, ...
Journal of cellular physiology 230 (2), 473-481, 2015
Mandat: National Fund for Scientific Research, Belgium
Tersedia di suatu tempat: 26
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
Mandat: US National Institutes of Health, Health Research Board, Ireland, UK Medical …
Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer
N Bovy, B Blomme, P Frères, S Dederen, O Nivelles, M Lion, O Carnet, ...
Oncotarget 6 (12), 10253, 2015
Mandat: National Fund for Scientific Research, Belgium
Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients
P Frères, N Bouznad, L Servais, C Josse, S Wenric, A Poncin, J Thiry, ...
BMC cancer 18, 1-9, 2018
Mandat: National Fund for Scientific Research, Belgium
Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis
C Josse, N Bouznad, P Geurts, A Irrthum, VA Huynh-Thu, L Servais, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 306 (3 …, 2014
Mandat: National Fund for Scientific Research, Belgium
Natural antisense transcripts: molecular mechanisms and implications in breast cancers
G Latgé, C Poulet, V Bours, C Josse, G Jerusalem
International journal of molecular sciences 19 (1), 123, 2018
Mandat: National Fund for Scientific Research, Belgium
Circulating microRNA-based screening tool for breast cancer
P Frères, S Wenric, M Boukerroucha, C Fasquelle, J Thiry, N Bovy, ...
Oncotarget 7 (5), 5416, 2015
Mandat: National Fund for Scientific Research, Belgium
Mutation of the iron‐sulfur cluster assembly gene IBA57 causes fatal infantile leukodystrophy
FG Debray, C Stümpfig, AV Vanlander, V Dideberg, C Josse, JH Caberg, ...
Journal of Inherited Metabolic Disease: Official Journal of the Society for …, 2015
Mandat: German Research Foundation
GREB1L variants in familial and sporadic hereditary urogenital adysplasia and Mayer‐Rokitansky‐Kuster‐Hauser syndrome
A Jacquinet, B Boujemla, C Fasquelle, J Thiry, C Josse, A Lumaka, ...
Clinical genetics 98 (2), 126-137, 2020
Mandat: National Fund for Scientific Research, Belgium
Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy
CE Onesti, F Boemer, C Josse, S Leduc, V Bours, G Jerusalem
Journal of translational medicine 17, 1-11, 2019
Mandat: National Fund for Scientific Research, Belgium
Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer
S Wenric, S ElGuendi, JH Caberg, W Bezzaou, C Fasquelle, ...
Scientific reports 7 (1), 17452, 2017
Mandat: National Fund for Scientific Research, Belgium
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
P Brown, Y Zhou
Database 2019, baz085, 2019
Mandat: Cancer Research UK, UK Medical Research Council
BRCA1 germline mutation and glioblastoma development: report of cases
M Boukerroucha, C Josse, K Segers, S El-Guendi, P Frères, G Jerusalem, ...
BMC cancer 15, 1-7, 2015
Mandat: National Fund for Scientific Research, Belgium
Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant …
CE Onesti, C Josse, A Poncin, P Frères, C Poulet, V Bours, G Jerusalem
Oncotarget 9 (72), 33719, 2018
Mandat: National Fund for Scientific Research, Belgium
Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse
CE Onesti, C Josse, D Boulet, J Thiry, B Beaumecker, V Bours, ...
Oncoimmunology 9 (1), 1761176, 2020
Mandat: National Fund for Scientific Research, Belgium
Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers
M Boukerroucha, C Josse, S ElGuendi, B Boujemla, P Frères, R Marée, ...
BMC cancer 15, 1-10, 2015
Mandat: National Fund for Scientific Research, Belgium
Oligodendrocyte development and myelinogenesis are not impaired by high concentrations of phenylalanine or its metabolites
R Schoemans, MS Aigrot, C Wu, R Marée, P Hong, S Belachew, C Josse, ...
Journal of inherited metabolic disease 33, 113-120, 2010
Mandat: US National Institutes of Health
Innovative methodology for the identification of soluble biomarkers in fresh tissues
B Costanza, A Turtoi, A Bellahcene, T Hirano, O Peulen, A Blomme, ...
Oncotarget 9 (12), 10665, 2018
Mandat: National Fund for Scientific Research, Belgium
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
S Di Cosimo, CM Ciniselli, S Pizzamiglio, V Cappelletti, M Silvestri, ...
Frontiers in Oncology 12, 1028825, 2023
Mandat: Government of Italy
Case report series: Aggressive HR deficient colorectal cancers related to BRCA1 pathogenic germline variants
MV Freire, M Martin, R Thissen, C Van Marcke, K Segers, E Sépulchre, ...
Frontiers in oncology 12, 835581, 2022
Mandat: National Fund for Scientific Research, Belgium
Informasi terbitan dan pendanaan ditentukan secara otomatis oleh program komputer